Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
421 JPY | -0.47% | -2.56% | -40.31% |
03-19 | SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March | MT |
03-19 | Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.31% | 190M | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- 4592 Stock
- News SanBio Company Limited
- Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform